➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Finafloxacin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for finafloxacin and what is the scope of freedom to operate?

Finafloxacin is the generic ingredient in one branded drug marketed by Merlion Pharms Gmbh and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Finafloxacin has forty-two patent family members in eighteen countries.

Summary for finafloxacin

International Patents:	42
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	33
Clinical Trials:	7
Patent Applications:	195
DailyMed Link:	finafloxacin at DailyMed

Recent Clinical Trials for finafloxacin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
MerLion Pharmaceuticals GmbH	Phase 2
MerLion Pharmaceuticals GmbH	Phase 1

See all finafloxacin clinical trials

US Patents and Regulatory Information for finafloxacin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free	Y			⤷ Try it Free
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014		DISCN	Yes	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for finafloxacin

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014	⤷ Try it Free	⤷ Try it Free
Merlion Pharms Gmbh	XTORO	finafloxacin	SUSPENSION/DROPS;OTIC	206307-001	Dec 17, 2014	⤷ Try it Free	⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for finafloxacin

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
European Patent Office	2928475	⤷ Try it Free
Russian Federation	2570731	⤷ Try it Free
Uruguay	32758	⤷ Try it Free
Mexico	2015007182	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.